HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association between lipoprotein subfraction profile and the response to hepatitis C treatment in Japanese patients with genotype 1b.

Abstract
Pegylated interferon and ribavirin combination therapy is the standard treatment for patients with chronic hepatitis C (CHC). Some groups have reported a relation between lipid values and response while others have reported that microsomal triglyceride transfer protein, a key enzyme in the assembly and secretion of lipoproteins, was related to hepatitis C virus (HCV). The aim of this study was to investigate the association between the lipoprotein profiles, classified according to size, and hepatitis C treatment and the usefulness for predicting the outcome of treatment. Forty-four patients with CHC (27 men and 17 women) were included in the study. The serum cholesterol and triglyceride (TG) levels in the lipoprotein subclasses were determined using high-performance liquid chromatography with gel permeation columns, which classified lipoproteins into 20 subfractions based on particle size. According to a univariate analysis, those who achieved an sustained viral response (SVR) had a significantly higher serum total cholesterol level, higher cholesterol levels in the low-density lipoprotein subfraction (25.5 nm in diameter) and the very low-density lipoprotein (VLDL) subfraction (44.5 and 36.8 nm), and a higher serum TG level in the VLDL subfraction (44.5 nm), compared with the corresponding values in the non-SVR group. Higher serum cholesterol and TG concentrations in the lipoprotein subfractions were predictive of an SVR to therapy for HCV infection with genotype 1b prior to the start of interferon treatment.
AuthorsH Mawatari, M Yoneda, K Fujita, Y Nozaki, Y Shinohara, H Sasaki, H Iida, H Takahashi, M Inamori, Y Abe, N Kobayashi, K Kubota, H Kirikoshi, A Nakajima, S Saito
JournalJournal of viral hepatitis (J Viral Hepat) Vol. 17 Issue 4 Pg. 274-9 (Apr 2010) ISSN: 1365-2893 [Electronic] England
PMID19708862 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Lipoproteins
  • Recombinant Proteins
  • Triglycerides
  • Polyethylene Glycols
  • Ribavirin
  • Cholesterol
  • peginterferon alfa-2b
  • peginterferon alfa-2a
Topics
  • Adult
  • Aged
  • Antiviral Agents (therapeutic use)
  • Asian People
  • Cholesterol (blood)
  • Female
  • Genotype
  • Hepacivirus (classification, genetics, isolation & purification)
  • Hepatitis C (diagnosis, drug therapy, virology)
  • Humans
  • Interferon alpha-2
  • Interferon-alpha (therapeutic use)
  • Lipoproteins (blood)
  • Male
  • Middle Aged
  • Polyethylene Glycols (therapeutic use)
  • Predictive Value of Tests
  • Prognosis
  • Recombinant Proteins
  • Ribavirin (therapeutic use)
  • Treatment Outcome
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: